Phase I Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers

NCT02268825 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
39
Enrollment
OTHER
Sponsor class

Stopped Merck requested to change MK-3475 dosing schedule; PI decided to close instead

Conditions

Interventions

Sponsor

University of Utah

Collaborators